Clinical Trials - September 11, 2014
Peptonic gets green light for new clinical study
Peptonic Medical’s applications for starting a phase 2b clinical study have been approved by the Swedish Medical Products Agency and the Central Ethical Review Board. According to the company, the aim of the study is to investigate the effect of Peptonic Medical’s product candidate Vagitocin in menopausal and post-menopausal women suffering from vaginal atrophy. “We are […]